
Caplin Point Laboratories Ltd is Rated Hold
2026-11-20 10:11:09Caplin Point Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Caplin Point Laboratories Ltd Hits Intraday Low Amid Price Pressure
2026-11-18 10:22:35Caplin Point Laboratories Ltd experienced a significant intraday decline on 18 Nov 2026, touching a low of Rs 2,073.5, down 7.89% from the previous close. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and heightened volatility.
Read More
Caplin Point Laboratories Ltd is Rated Hold
2026-11-09 10:10:40Caplin Point Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Caplin Point Laboratories Ltd is Rated Hold
2026-10-28 10:10:44Caplin Point Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-10-27 08:03:47Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and relative performance against the Sensex suggest cautious optimism among investors.
Read More
Caplin Point Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Signals
2026-10-22 08:03:56Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a cautious outlook for investors amid recent price fluctuations.
Read More
Caplin Point Laboratories Ltd: Technical Momentum Shifts Signal Cautious Outlook
2026-10-21 08:04:50Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s long-term returns continue to outperform the Sensex, underscoring its resilience amid market volatility.
Read More
Caplin Point Laboratories Ltd is Rated Hold
2026-10-17 10:10:05Caplin Point Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 October 2026, providing investors with the latest insights into the company's performance and outlook.
Read More
Caplin Point Laboratories Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals
2026-10-14 08:04:04Caplin Point Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of mid-October 2026. Despite a strong year-to-date return of 28.3%, the stock’s recent price action and technical indicators suggest a period of consolidation and caution for investors in the pharmaceuticals and biotechnology sector.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
19-Nov-2026 | Source : BSETranscript for Earnings call - Q2 - FY 2026-27
Update On US FDA Inspection At The Facility Of Caplin Steriles Limited Subsidiary Of The Company
17-Nov-2026 | Source : BSEClassification of US FDA Inspection at the facility of Caplin Steriles Limited subsidiary of the Company as OAI
Board Meeting Outcome for Meeting Held On November 12 2026
12-Nov-2026 | Source : BSEBoard Meeting Outcome for Meeting Held on November 12 2026
Corporate Actions
No Upcoming Board Meetings
Caplin Point Laboratories Ltd has declared 200% dividend, ex-date: 18 Sep 26
Caplin Point Laboratories Ltd has announced 2:10 stock split, ex-date: 19 Oct 16
No Bonus history available
No Rights history available